Literature DB >> 20704556

Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain.

N Jantaratnotai1, C Schwab, J K Ryu, P L McGeer, J G McLarnon.   

Abstract

We have investigated physical properties of microvasculature and vessel association with microglial clusters in cortical tissue from Alzheimer disease individuals, classified as severe (ADsev) or mild (ADmild), and nondemented controls (ND). Immunostaining with laminin or von Willerbrand factor demonstrated numbers of microvessels and microvascular density were significantly higher in ADsev cases compared with levels in ADmild or ND cases suggesting proangiogenic activity in ADsev brain. Evidence for extravascular laminin immunoreactivity was found in ADsev tissue and was largely absent in ADmild and ND cases suggesting vascular remodeling in ADsev brain included abnormalities in blood vessels. Microgliosis was progressively increased from ND to ADmild to ADsev with the latter demonstrating areas of clustered microglia (groupings of three or more cells) rarely observed in ADmild or ND cases. Microglial clusters in ADsev brain were in close proximity with extravascular laminin and also plasma protein, fibrinogen, implicating vascular perturbation as a component of inflammatory reactivity. ADsev brain also exhibited elevated levels of the pro-inflammatory/angiogenic factors tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF) in association, relative to non-association, with microglial clusters. The presence of extravascular laminin and fibrinogen and the vascular modifying factors, TNF-α and VEGF in localization with clusters of activated microglia, is consistent with microglial-induced vascular remodeling in ADsev brain. Microglial-vascular reciprocal interactions could serve a critical role in the amplification and perpetuation of inflammatory reactivity in AD brain.

Entities:  

Mesh:

Year:  2010        PMID: 20704556     DOI: 10.2174/156720510793499039

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  14 in total

1.  Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.

Authors:  Marta Cortes-Canteli; Larissa Mattei; Allison T Richards; Erin H Norris; Sidney Strickland
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 4.673

2.  Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy.

Authors:  Mariel G Kozberg; Irvin Yi; Whitney M Freeze; Corinne A Auger; Ashley A Scherlek; Steven M Greenberg; Susanne J van Veluw
Journal:  Brain Commun       Date:  2022-09-26

3.  Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.

Authors:  Y C Chung; A Kruyer; Y Yao; E Feierman; A Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2016-06-13       Impact factor: 5.824

Review 4.  Fibrinogen and altered hemostasis in Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Daria Zamolodchikov; Hyung Jin Ahn; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain.

Authors:  Nattinee Jantaratnotai; Jae K Ryu; Claudia Schwab; Patrick L McGeer; James G McLarnon
Journal:  Int J Alzheimers Dis       Date:  2011-09-29

6.  Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice.

Authors:  Melinda E Lull; Shannon Levesque; Michael J Surace; Michelle L Block
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.

Authors:  Kaan E Biron; Dara L Dickstein; Rayshad Gopaul; Wilfred A Jefferies
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

Review 8.  Imaging of cerebrovascular pathology in animal models of Alzheimer's disease.

Authors:  Jan Klohs; Markus Rudin; Derya R Shimshek; Nicolau Beckmann
Journal:  Front Aging Neurosci       Date:  2014-03-13       Impact factor: 5.750

Review 9.  Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.

Authors:  Magd A Kotb
Journal:  Int J Mol Sci       Date:  2012-07-17       Impact factor: 6.208

10.  Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer's disease.

Authors:  Jae K Ryu; T Cho; Hyun B Choi; N Jantaratnotai; James G McLarnon
Journal:  J Neuroinflammation       Date:  2015-08-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.